Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Isabelle BosAnne M Fagan

Abstract

Vascular factors increase the risk of Alzheimer's disease (AD). We investigated the associations between such factors, longitudinal AD cerebrospinal fluid biomarkers, and cognition. 433 cognitively normal participants were classified into four biomarker groups using their baseline amyloid (A+/-) and tau status (T+/-). 184 participants had undergone serial cerebrospinal fluid collection. Frequencies of risk factors and the Framingham Risk Score (FRS) were compared, and we tested the influence of risk factors on change in biomarker concentrations and cognition. The absence of obesity, presence of hypertension, and a high FRS were associated with an increase in tau levels, particularly in A+T+ individuals. Risk factors were not associated with amyloid. Depression was associated with higher cognitive scores, whereas high FRS was associated with lower scores and a faster decline. Our results demonstrate that vascular risk factors may enhance neurodegeneration but not amyloid accumulation in preclinical AD.

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Jun 1, 1988·Neurology·E GroberR Dresner
Aug 2, 2003·Annals of Neurology·Pau PastorAlison M Goate
Nov 25, 2005·Journal of Geriatric Psychiatry and Neurology·Mary Coats, John C Morris
Nov 7, 2007·Neurology·M M MielkeC G Lyketsos
Jan 24, 2008·Circulation·Ralph B D'AgostinoWilliam B Kannel
Apr 22, 2009·International Journal of Geriatric Psychiatry·Elizabeth Guerrero-BerroaMichal Schnaider Beeri
Sep 15, 2009·Journal of Alzheimer's Disease : JAD·Julie A SchneiderDavid A Bennett
Nov 23, 2011·Neurology·E D VidoniUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Feb 15, 2012·Current Alzheimer Research·Huan CaiBronwen Martin
Apr 5, 2012·Current Alzheimer Research·Rebecca P GelberLon R White
Apr 11, 2012·Journal of Neuropathology and Experimental Neurology·Peter T NelsonThomas G Beach
Sep 14, 2012·Neurology·Raymond Y LoUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Nov 12, 2014·BMC Medicine·Renée F A G de Bruijn, M Arfan Ikram
Nov 12, 2014·BMC Medicine·Johannes Attems, Kurt A Jellinger
Sep 27, 2015·Biochimica Et Biophysica Acta·Prashanthi Vemuri, David S Knopman
Nov 10, 2015·The New England Journal of Medicine·UNKNOWN SPRINT Research GroupWalter T Ambrosius
Mar 12, 2016·Journal of Alzheimer's Disease : JAD·Samantha L AllisonDenise Head
May 4, 2016·The Lancet. Psychiatry·Saira Saeed MirzaM Arfan Ikram
Aug 16, 2016·Journal of Neuropathology and Experimental Neurology·Lilah M BesserWalter A Kukull
Apr 12, 2017·JAMA : the Journal of the American Medical Association·Rebecca F GottesmanThomas H Mosley
Apr 30, 2017·Scientific Reports·Stephan MüllerChristoph Laske
May 10, 2017·Neurobiology of Aging·Isabelle BosPieter Jelle Visser
Oct 13, 2017·Annals of Neurology·Prashanthi VemuriClifford R Jack
Oct 21, 2017·Brain : a Journal of Neurology·Alexandre BejaninGil D Rabinovici
Feb 8, 2018·PloS One·Mony J de LeonUNKNOWN National Alzheimer’s Coordinating Center
Mar 5, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Suzanne E SchindlerAnne M Fagan
Apr 15, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Clifford R JackUNKNOWN Contributors
Mar 1, 2019·Neurology·Jackie BoschUNKNOWN HOPE-3 Investigators

❮ Previous
Next ❯

Citations

Feb 8, 2020·JAMA Network Open·Theresa KöbeUNKNOWN Presymptomatic Evaluation of Experimental or Novel Treatments for Alzheimer Disease (PREVENT-AD) Research Group
Sep 15, 2020·Laboratory Medicine·Luisa AgnelloMarcello Ciaccio
Dec 1, 2020·Journal of Alzheimer's Disease : JAD·Linda J C van Waalwijk van DoornH Bea Kuiperij
Feb 12, 2021·Arteriosclerosis, Thrombosis, and Vascular Biology·Elizabeth E Moore, Angela L Jefferson
Feb 2, 2021·Journal of Alzheimer's Disease : JAD·Guang-Xiang YuUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Feb 2, 2021·NeuroImage. Clinical·Lauren N KoenigJohn C Morris
Feb 23, 2021·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Tobias MöllersHermann Brenner
Mar 13, 2021·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Carol A DerbyMaria M Brooks
Apr 29, 2021·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·Dongxue WangHailong Xie
Jul 27, 2021·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Ruixue SongWeili Xu
Sep 11, 2021·Free Radical Biology & Medicine·Owen Davis SandersJayalekshmi Archa Rajagopal
Oct 17, 2021·Alzheimer's Research & Therapy·Tengfei GuoUNKNOWN Alzheimer’s Disease Neuroimaging Initiative

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.